Sullivan Timothy Eugene
SEC insider (Form 3/4/5 filer). CIK 0001707000. Chief Financial Officer at Apellis Pharmaceuticals, Inc. (APLS). 33 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Sullivan Timothy Eugene has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief Financial Officer
Sullivan Timothy Eugene
CIK: 0001707000
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect29.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect58.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect29.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect140.9K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferIndirect71.5K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect30.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect30.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect58.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 29,070 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 58,140 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 29,070 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 140,945 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 71,492 | - | $0 | Indirect |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 30,620 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 30,620 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 58,140 | - | $0 | Direct |
1-10 of 33 transactions